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Abstract
Background: Paravertebral block (PVB) is an effective analgesic technique for post-thoracotomy pain, whereas there is no clear
proof on how it can be more effective. We aimed to assess if the pleural integrity has a significant effect on thoracic PVB analgesia.
Methods: Data of patients who underwent thoracotomy and paravertebral catheterization in Menoufia University Hospitals, be-
tween November 2010 and December 2014 were retrospectively collected. Patients were classified into two groups; group A, where
the parietal pleura was disrupted, and group B, where there was no pleural tear. Pain scores and pulmonary functions were compared
between both groups. Also the frequency of PVB analgesia and the need for supplementary drugs taken as well as the use of rescue
pain medications were assessed in both groups.
Results: 132 patients were analyzed; group A (n ¼ 68) patients with pleural disruption and group B (n ¼ 64) patients with intact
pleural. There was no statistical significant difference regarding age, sex, body mass index, American Society of Anesthesiologists
score (ASA), diagnosis, and operative details. Pain scores were significantly lower in group B, where no pleural tear. Pulmonary
functions significantly improved among intact pleura group. Significant increases in the frequency of PVB analgesia, supple-
mentary drugs taken in postoperative period and in the use of rescue drugs were observed in patients with pleural disruption.
Complications were higher in pleural disruption group.
Conclusion: Preservation of integrity of the parietal pleura is essential for the quality thoracic PVB.
Copyright © 2016, The Egyptian Society of Cardio-thoracic Surgery. Publishing services by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Post-thoracotomy pain remains a challenging clinical problem that may be associated with increased morbidity and
mortality. Previous studies have found that ineffective pain control may lead to serious pulmonary complications
because of insufficient clearance of secretions, mucous plugging, and atelectasis [1].* Corresponding author. Tel.: þ20 1277280480.
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article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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spinal (intercostal) nerve, the dorsal ramus, the rami communicantes and the sympathetic chain. Application of local
anesthetic within the paravertebral space produces unilateral somatic and sympathetic block, which is better for
unilateral surgical procedures of the chest and abdomen [2].
Thoracic PVB was originally described by Sabanathan et al. [3], and they subsequently updated this technique by
inserting an indwelling extrapleural catheter for infusion of local anesthetic drugs (LA) in the postoperative period.
Several studies assessed the analgesic effectiveness of thoracic PVB [4e6]. The use of Seldinger technique for catheter
insertion under visionwith a trocar passed one space below the thoracotomywound posteriorly is easy and safemethod.
To avoid pleural tear, once the catheter tip becomes visible in the extra-pleural space through the thoracotomy wound,
the catheter is passed through the trocar and positioned to lie vertically covering two to three intercostal spaces [7,8].
We applied this study to evaluate the effect of keeping the pleural membrane intact on the success of thoracic PVB
catheter analgesia.
2. Patients and methods
2.1. Study design
After approval of the study protocol by the Menoufia Ethics Committee, we retrospectively selected patients from a surgical
database records in the Cardiothoracic Surgery Department, Menoufia University Hospital, Egypt. All patients had thoracotomy
and paravertebral block catheter for different surgical procedures including pulmonary lobectomy for primary lung cancer, lung
abscess, or bronchiectasis, and repair of bronchopleural fistula, resection of posterior mediastinal mass, from November 2010 to
December 2014.
Exclusion criteria included; patients who were under 18 or over 75 years of age, those with a history of severe cardiac disease,
hepatic or renal failure, those with American Society of Anesthesiology class (ASA) IVor higher, those who underwent resection of
the pleura or chest wall, those with bleeding tendencies or were receiving anticoagulant therapy, those with a known allergy to local
anesthetic agents, those having a neurological disorder, and those receiving opioid therapy for chronic pain treatment.
The surgical approach in all patients was a muscle sparing posterolateral thoracotomy through the 5th intercostal space, usually
extending from the midscapular to the anterior axillary line with an incision length of 10e12 cm. At the end of the procedure all
patients were extubated.
Patients were classified into two groups, group A (n¼ 68) where there was pleural disruption, and group B (n¼ 64) with intact
pleural membrane.
Postoperative pain and pulmonary functions were the primary outcomes, where the frequency of paravertebral block analgesia
(PVB), supplementary drugs (paracetamol) and the postoperative complications were the secondary outcomes.
Visual analogue scale (VAS) was used for assessment of postoperative pain degree at one, six, 12, 24, 48, and 72 h. The scale was
used from zero (no pain) to 10 (intolerable pain) usually by the cardiothoracic surgery resident or a well-trained nurse. A score >3
indicated pain requiring an analgesic administration in the form of Bupivacaine in the paravertebral catheter as 20 ml Bupivacaine
0.5% in 5 ml increments (Marcain Plain; AstraZeneca, Egypt®) until the VAS for pain score at rest was three or less.
To ensure a good cough effort and excellent physiotherapy, every patient was strongly encouraged to take analgesia without
hesitation, if needed, as a supplementary drug in the form of an intravenous infusion of 1 g of paracetamol (Paracetamol, Egyptian
European Pharmaceutical Industry, Egypt®) every 8 h in the first 2 days then oral paracetamol during the following 5 days. Every
postoperative patient was not allowed to take supplementary drug not <8 h apart, which indicated that the maximum frequency of
supplementary drugs use allowed was three times a day. In the case of analgesic failure with paracetamol, meperidine (Pethedin
50 mg), a synthetic opioid, (0.5e1 mg/kg/dose, as bolus subcutaneous or intravenous injection) was given. It was given maximally
every 12 h and was used as a rescue medication.
Pulmonary function tests were performed by using a spirometry (Cosmed®). We used forced expiratory volume in first second
(FEV1) percentage of the predicted both preoperative and three days postoperative and usually done by a well-trained
pulmonologist.
2.2. Technique of intraoperative PVB catheter insertion
Before closure of the thoracotomy, an indwelling extrapleural catheter (Tuohy 18G; Braun,Melsungen, Germany®) was inserted
intraoperatively by the surgeon. The classic surgical method for insertion of extra-pleural catheters is creation of a tunnel lateral to
the parietal pleura and placing the catheter as deep as possible in this tunnel. But this method was found to be associated with a
significant leak of the local anesthetic into the pleural space resulting in a less effective postoperative pain control. So instead of
creating a tunnel into the parietal pleura, we usually use a Seldinger technique of catheter insertion under vision and intraoperatively
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the extra-pleural space through the thoracotomy wound, the catheter was passed through the trocar and positioned to lie vertically
covering two to three intercostal spaces. About eight ml of 2.5% Bupvicaine were injected into the catheter to ensure ideal position.
Ballooning or tenting of the parietal pleural membranewithout significant leakage of the local anesthetic drug into the pleural cavity
is a good predictor of correct catheter position. The catheter was fixed against slippage by 3/0 silk sutures. We believe that this
method of insertion offers better pain control as the extra-pleural space is closed above the catheter tip allowing no leakage into the
pleural cavity and there was coverage of more than one intercostal space in contrary to creating an open tunnel. The PVB catheter
was placed to allow the local anesthetic to distribute into two to three intercostal spaces above and below the level of the thora-
cotomy. Then, following lung re-inflation before chest closure, administration of LA was initiated through the PVB catheter,
producing pleural tenting [3,7,8]. We supposed that intact pleura could contain administered LAwell within the extrapleural space
and pleural tenting was created (Fig. 1), whereas the disrupted pleura hardly made pleural tenting with almost no LA accumulated
extrapleurally (Fig. 2). In our study we used the local anesthetic in the form of 20 ml Bupivacaine 0.5% in 5 ml increments.2.3. Statistical analysis
Continuous variables, such as age were expressed as the mean ± S.D. and compared by unpaired t-test. Categorical variables
were expressed by number (n) and frequencies (%). The c2-test was used to compare the proportions. Statistical analyses were
carried out using the ManneWhitney U-test to analyze pain scores, and Wilcoxon signed rank test to analyze pulmonary functions.Fig. 1. The PVB catheter lies between 2 forceps with intact pleural membrane.
Fig. 2. Paravertebral block catheter in place with its tip seen held with forceps and emerges through the parietal pleural tear.
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software (SPSS, IBM, Chicago, IL, USA).
3. Results
132 patients underwent thoracotomy and thoracic PVB analgesia for different surgical procedures. There were no significant
differences between both groups with respect to age, gender, body mass index (BMI), ASA score, pathological diagnosis, types of
operation, and mean duration of the surgical procedure. There were statistically significant differences between both groups as
regards postoperative day of discharge where it was 4.2 day in group A, versus 2.87 day in group B. Also there was significant
difference in percentage of patients needed rescue drugs where it was higher in group A (disrupted pleura), Table 1.
There was statistically significant lower mean values of postoperative pain scores in group B than in group A, throughout the first
postoperative 24 h, whereas during the second and third postoperative days, VAS for pain scores were lower in group B but without
statistical significant difference, Table 2.
Table 3 presented the changes in postoperative FEV1% of predicted value from preoperative one in both groups where it was
improved significantly in group B, (p ¼ 0.03) and the improvement was not statistically significant in group A (p ¼ 0.08).
The need for PVB analgesia with Bupivacaine was significantly lower among patients in group B (with intact pleura) during the
first two postoperative days, (p < 0.001). The use of supplementary drugs was also significantly lower in group B, during post-
operative days 1, 2 (POD-1, 2) where (p < 0.001), as in Table 4.Table 1
Demographic and operative data.
Group A (n ¼ 68) Group B (n ¼ 64) P-value
Age (mean ± SD)a 61.3 ± 8.36 58 ± 9 0.93
Sex N (%)b
Male 42 (61.7) 40 (62.5) 0.92
Female 26 (38.3) 24 (37.5)
BMI(mean ± SD)a 20.8 ± 2.8 19.6 ± 2.7 0.7
ASA score N (%)b
II 42 (61.7) 38 (59.4) 0.77
III 26 (38.3) 26 (40.6)
Diagnosis N (%)b
Lung cancer 13 (19.1) 10 (16.6) 0.46
Lung abscess 20 (29.4) 20 (31.2)
Bronchiectasis 15 (22) 18 (28)
Spontaneous pneumothorax 16 (23.5) 14 (21.8)
Mediastinal Mass 4 (5.9) 2 (3.1)
Operation N (%)b
Lobectomy 48 (70.6) 48 (75) 0.71
BPF repair 16 (23.5) 14 (21.8)
Mediastinal mass resection 4 (5.9) 2 (3.1)
Operative time/min (mean ± SD)a 165 ± 23 170 ± 23.8 0.8
POD of discharge (mean ± SD)a 4.19 ± 1.54 2.87 ± 1.18 <0.001
Patients needed rescue drug N (%)b 16 (23.5) 6 (9.4) 0.029
a Student t-test.
b Chi-square test, BMI:body mass index, ASA: American Society of Anesthesiologists score, BPF: Bronchopleural fistula, POD:postoperative
day.
Table 2
Visual analogue scale for postoperative pain score.
Postoperative hours (mean ± SD) Group A (n ¼ 68) Group B (n ¼ 64) P-value
1 h 4.68 ± 1.26 3.67 ± 1.29 0.001*
6 h 2.8 ± 1.28 2.3 ± 0.79 0.01*
12 h 2.2 ± 0.86 1.3 ± 0.58 0.001*
24 h 2.03 ± 0.77 1.09 ± 0.42 0.001*
48 h 1.04 ± 0.46 0.76 ± 0.25 0.33
72 h 0.75 ± 0.44 0.69 ± 0.38 0.93
Test of significance is mann-whitney U-test, p-value <0.05 is statistically significant. Asterisk (*) means highly statistical significance.
Table 3
Changes in forced expiratory volume in first second.
Preoperative FEV1% Postoperative FEV1% P-value
Group A (n ¼ 68) 59.7 ± 15.43 61.2 ± 15.41 0.082
Group B (n ¼ 64) 60.1 ± 15.4 64.2 ± 14.7 0.03
FEV1: Forced expiratory volume in first second, all values in mean ± SD, Test of significance is wilcoxon signed rank test.
Table 4
Frequency of use of paravertebral block drugs and supplementary drugs during the first three postoperative days.
POD Group A (n ¼ 68) Group B (n ¼ 64) P-value
Frequency of paravertebral block drug use
POD-0 3.51 ± 0.5 2.98 ± 0.46 0.001
POD-1 3.98 ± 0.9 2.59 ± 0.5 <0.001
POD-2 2.38 ± 0.8 1.7 ± 0.55 <0.001
POD-3 1.26 ± 0.9 1.2 ± 0.98 0.72
Frequency of supplementary drug use
POD-0 1.27 ± 0.9 1.2 ± 0.9 0.64
POD-1 1.56 ± 0.6 0.75 ± 0.7 <0.001
POD-2 1.18 ± 0.77 0.62 ± 0.74 <0.001
POD-3 0.43 ± 0.66 0.5 ± 0.87 0.57
POD:postoperative day, All values in mean ± SD, Test of significance is student t-test.
69A.L. Dokhan et al. / Journal of the Egyptian Society of Cardio-Thoracic Surgery 24 (2016) 65e72Table 5 presented the postoperative complications in both groups, where atrial fibrillation (AF) and prolonged air leak were
higher in group A (disrupted pleura) than that in group B, (p¼ 0.19, 0.5 respectively). Nausea& vomiting were significantly higher
among patients in group A (p ¼ 0.02).4. Discussion
The use of this technique of PVB catheter insertion for control of postoperative pain was done to try a simple and
effective technique for analgesia as well as to avoid the side effects of systemic opioids and even thoracic epidural
blocks. As the thoracotomy incision is one sided, there is no need for extended block. This technique has minimal
hemodynamic effects, maintains pulmonary functions and is devoid of systemic morphine side effects. Thoracic PVB
with a catheter using Bupivacaine as a local anesthetic provides better postoperative analgesia than intravenous
morphine as an analgesic agent in patients undergoing pulmonary surgery via a posterolateral thoracotomy incision
[9].
4.1. Assessment of pain score
As regards the effect of paravertebral block on postoperative pain in both groups, we observed that paravertebral
block produced significant decrease in VAS scores postoperatively in group B (with intact pleura) in the first 24 h as
compared to group A (pleural disruption group). Patients in group B reported less pain than patients in group A at 1, 6,
12, and 24 h postoperatively.Table 5
Postoperative complications in both groups.
Group A (n ¼ 68) Group B (n ¼ 64) P-value
Atrial Fibrillation 4 (5.9) 1 (1.5) 0.19
Prolonged air-leak 5 (7.3) 3 (4.7) 0.5
Nausea & vomiting 12 (17.6) 3 (4.7) 0.02
All values in number & percentage, Test of significance is chi-square.
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continuous PVB using Bupivacaine to intravenous metamizol as a systemic analgesic. They found that PVB decreased
pain severity significantly than the systemic analgesic up to 72 h postoperatively [10].
Kairaluoma et al. found nearly the same results as those in our study when they compared pre-incisional PVB
(single injection) with Bupivacaine to IVOxycodone for relieving postoperative pain after breast surgery. PVB in their
study reduced chronic pain symptoms up to 12 months postoperatively [11].
Also, our results regarding group B, were similar to that reported by Asida et al., who reported significant decrease
in VAS Pain scores during the first postoperative 16 h when they used Bupivacaine 0.5% into the thoracic PVB
catheter [9].
In group B (no pleural tear) we had similar results to that reported by Ibrahim et al. who reported significant
decrease in VAS Pain scores during the first postoperative 72 h when they used Bupivacaine 0.5% into the thoracic
PVB catheter to compare its safety and efficacy between two groups anterior thoracotomy and posterior thoracotomy
[12].
4.2. Assessment of pulmonary functions
In our study we noticed an improvement in FEV1% in both groups from preoperative to postoperative values, but
the improvement was statistically significant in group B (no pleural tear), and the increase in postoperative FEV1%
was about 18.5%.
This was different from Esme et al., who reported postoperative decrease in FEV1% by about 6.25%, when they
used Bupivacaine in PVB catheter on 15 patients [13].
Hill et al. showed that there was no significant difference between single-dose multi-level PVB and systemic
analgesia using morphine as regards peri-operative pulmonary functions. They used forced vital capacity (FVC) and
forced expiratory volume in first second (FEV1) as measurements of pulmonary functions [14].
The results of Bilgin et al. were against our results as they observed that there was a decrease in postoperative FEV1
values in both PVB and systemic analgesia group when compared to the preoperative values. On the first postoperative
day when the mean FEV1 values were compared with the preoperative values, in group I (PVB), FEV1 was 38% and
in group II (systemic analgesia), FEV1 was 55%of the preoperative values [10].
We think that these differences because they used the standard anesthetic technique of catheter insertion which was
done by the anesthesiologist before induction of anesthesia when the patient is still awake. They used the loss of
resistance technique which has higher incidence of pleural disruption, which in turn lowers the analgesic effect of
local anesthetic injected into the catheter, and do not have positive impact on pulmonary functions.
4.3. Assessment of drug use (PVB Bupivacaine and supplementary drugs)
We noticed a statistically significant decrease in the frequency of PVB Bupivacaine use in group B than in disrupted
pleura group (group A), during the first two postoperative days, (p-value ¼ 0.001), and the need for analgesia
decreased significantly throughout the days from postoperative day zero to three in both groups.
Also the frequency of supplementary drug use decreased significantly in POD-1 and POD-2, in both groups, but the
decrease was more significantly different in group B than in the disrupted pleura group.
Our results were similar to that reported by Komatsu et al., where they observed a significant decrease in sup-
plementary drug use between intact and disrupted pleura group in the favor of intact pleura group, but they used
NSAIDS not more than four times per day as supplementary drug and we used paracetamol infusion not more than
three times per day [15].
Also Esme et al., used paracetamol 1 gm infusion as a supplementary drug where 26% (4/15) of patients in the
Bupivacaine group needed supplementary drugs during the first three postoperative days [13].
The need for rescue drugs during the first three postoperative days in disrupted pleura group (group A) was
significantly higher than in intact pleura group (group B). We had 23.5% (16/68) in group A versus 9.4% (6/64) in
group B who needed rescue medications in the form of (meperidine 50 mg) in a dose of 0.5e1 mg/kg, subcutaneous or
intravenous injection maximally twice per day. This was similar to Komatsu et al. [15], where they had 26.9% (21/78)
of patients in pleural tear group who needed rescue drug, versus 14.1% (11/78) in intact pleura group. But in contrast
to our study, they used intramuscular pentazocin as rescue medication.
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infusion use on POD-1, 2 among the patients with pleural disruption was significantly higher than those without. This
finding should well support the hypothesis that the disrupted pleura cannot contain the infused LA sub-pleurally,
which is likely to diminish the analgesic effectiveness.
4.4. Assessment of complications
The PVB catheter creates a very limited extrapleural space, that could accommodate little amounts of local
anesthesia (LA). An extra amount of the LAwas supposed to leak from that sub-pleural space if the pleural membrane
is injured, while pleural tenting will occur if the pleura remains intact. We stopped the LA and removed the PVB
catheter when postoperative chest tubes were removed. Almost all of the patients received two to three days of PVB.
The LA leaking from the sub-pleural space was drained through a chest tube. Therefore, there could be a remote
possibility of LA toxicity.
The dose of Bupivacaine (20 ml 0.5%) which was used in our study was similar to several studies such as Andre and
colleagues who used the same dose in a catheter for breast surgery [16]. Also, Richardson and colleagues used the
same dose in a large study [17].
Postoperative atrial fibrillation (AF) was noticed more in group A (pleural disruption), where there was 5.9% (4/68)
of patients and in intact pleura group there was 1.5% (1/64) of patients having AF. This was near from results reported
by Komatsu et al. who reported 3.9% (3/78) of patients in the pleural tear group having AF, and only one case 1.3% (1/
78) of intact pleura group having AF [15].
Regarding drug pharmacokinetics, Burlacu et al. [18] found that, after paravertebral administration of LA, the
maximum plasma concentration of the medications was within the safe range or was less than that of the effective
levels after intravenous administration.
Karmakar et al. [19] reported that infusion of radioopaque contrast medium in the sub-pleural space remained in the
paravertebral space. This finding strongly suggests that the analgesic effect induced by PVB can be greatly referred to
a peripheral mechanism of action.
Regarding nausea and vomiting, we observed a statistical significant difference between both our groups where in
group A (pleural disruption) we had 17.6% (12/68) of patients, and in group B (without pleural disruption), there was
4.7% (3/64) of patients who developed nausea and vomiting. Our results were similar to that reported by Komatsu
et al., [15] who found that 19.2% (15/78) of patients in pleural tear group developed nausea and vomiting, while in
intact pleura group only 1.3% (1/78) of patients had nausea and vomiting.
Fagenholz et al. [20] also advocated the importance of intact pleura when considering the adverse effects of PVB.
These authors stated that, once the LA enters the pleural space through the pleural tears, the absorption of the LA from
the pleural space is more rapid compared with that from the paravertebral space; this, in turn, might result in systemic
toxicity, causing nausea and convulsions. Our study showed the higher incidence of postoperative nausea/vomiting in
patients with pleural disruption (P < 0.02), which could be well understood by the report of Fagenholz et al. [20];
further, the total incidence of nausea was much lower compared with that reported for that happened with epidural
block.
The main limitation of this study was the subjective nature of pain, which was difficult to measure precisely.5. Conclusion
The use of thoracic PVB catheter is safe, and effective in post-thoracotomy pain control especially with preser-
vation of the integrity of parietal pleura without disruption, through careful and meticulous paravertebral block
catheter insertion. Also additional research should be applied in a prospective study to compare the intraoperative
Seldinger technique to the classic surgical technique of catheter insertion.Conflict of interest
No conflicts of interest.
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